• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国耐多药结核病趋势:来自临床结核病中心的数据。

Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre.

机构信息

National Tuberculosis Clinical Laboratory, Beijing Chest Hospital, Capital Medical University, Beijing, Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.

Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.

出版信息

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):990-995. doi: 10.5588/ijtld.17.0086.

DOI:10.5588/ijtld.17.0086
PMID:28826447
Abstract

OBJECTIVE

To describe the trends in prevalence of drug-resistant tuberculosis (TB) among in-patients in Beijing Chest Hospital, Beijing, China, using a 10-year retrospective study.

DESIGN

From 2005 to 2014, 18 310 in-patients with TB were recruited for the study, most of whom were referrals; no distinction was made between new and previously treated cases. Drug susceptibility testing (DST) was performed in culture-positive cases using the proportion method to determine multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). Risk factors associated with drug resistance were identified.

RESULTS

A total of 5141 (28.0%) samples were culture-positive. DST results showed that 860 (16.7%) cases were MDR-TB and 176 (3.4%) were XDR-TB. MDR-TB and XDR-TB were detected in respectively 21.2% and 12.5% of new cases. The rate of MDR-TB and XDR-TB gradually increased from 2005, with MDR-TB reaching a peak in 2008 and XDR-TB in 2009. These data closely mirror national survey data on this region, patient age and occupation.

CONCLUSION

Trends in MDR-TB and XDR-TB prevalence during the past decade and their inflection points were determined, which complemented reports from previous national surveys. This information is useful for fighting TB in China.

摘要

目的

采用回顾性研究,描述北京胸科医院住院结核病患者中耐药结核病的流行趋势。

设计

2005 年至 2014 年,共招募了 18310 例结核病住院患者,其中大部分为转诊患者;未对新发和复治病例进行区分。采用比例法对培养阳性病例进行药物敏感性试验(DST),以确定耐多药结核病(MDR-TB)和广泛耐药结核病(XDR-TB)。确定与耐药相关的危险因素。

结果

共 5141 例(28.0%)标本培养阳性。DST 结果显示,860 例(16.7%)为 MDR-TB,176 例(3.4%)为 XDR-TB。新发病例中分别有 21.2%和 12.5%为 MDR-TB 和 XDR-TB。MDR-TB 和 XDR-TB 的检出率从 2005 年开始逐渐上升,MDR-TB 在 2008 年达到高峰,XDR-TB 在 2009 年达到高峰。这些数据与该地区全国调查数据、患者年龄和职业密切相关。

结论

确定了过去十年间 MDR-TB 和 XDR-TB 流行率的趋势及其转折点,补充了以往全国调查的报告。这些信息对中国的结核病防治工作具有重要意义。

相似文献

1
Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre.中国耐多药结核病趋势:来自临床结核病中心的数据。
Int J Tuberc Lung Dis. 2017 Sep 1;21(9):990-995. doi: 10.5588/ijtld.17.0086.
2
Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.广泛耐药结核病患者中的广泛耐药结核病患病率:一项基于医院的回顾性研究。
Indian J Med Res. 2009 Oct;130(4):392-5.
3
Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.2011年越南耐多药结核病患者对二线抗结核药物的耐药率
Western Pac Surveill Response J. 2016 Jun 8;7(2):35-40. doi: 10.5365/WPSAR.2016.7.2.002. eCollection 2016 Apr-Jun.
4
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.中国北京耐多药结核分枝杆菌的流行情况及分子特征:2006年与2012年对比
BMC Microbiol. 2016 May 12;16:85. doi: 10.1186/s12866-016-0699-2.
5
Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review.中国国家结核病临床中心广泛耐药结核病及附加耐药的流行状况和治疗结局:一项为期五年的回顾性研究。
J Infect. 2017 Nov;75(5):433-440. doi: 10.1016/j.jinf.2017.08.005. Epub 2017 Aug 11.
6
Drug Resistance Characteristics of Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China.中国结核病患者分离株对 12 种抗结核药物的耐药特征。
Front Cell Infect Microbiol. 2019 Nov 5;9:345. doi: 10.3389/fcimb.2019.00345. eCollection 2019.
7
Laboratory-Based Surveillance of Extensively Drug-Resistant Tuberculosis in Eastern China.中国东部广泛耐药结核病的实验室监测
Microb Drug Resist. 2017 Mar;23(2):236-240. doi: 10.1089/mdr.2016.0075. Epub 2016 Oct 18.
8
Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China.中国山东省广泛耐药结核病的流行病学趋势与转归
BMC Infect Dis. 2017 Aug 9;17(1):555. doi: 10.1186/s12879-017-2652-x.
9
Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.耐多药结核病广泛耐药危险因素:病例对照研究。
Int J Tuberc Lung Dis. 2018 Jan 1;22(1):54-59. doi: 10.5588/ijtld.17.0387.
10
Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.缅甸广泛耐药结核病:二线药物耐药相关的负担和突变。
Int J Tuberc Lung Dis. 2018 Jan 1;22(1):47-53. doi: 10.5588/ijtld.17.0321.

引用本文的文献

1
Prevalence and epidemic pattern of ecdemic multidrug-resistant tuberculosis during 2012-2022 in Hangzhou, China: implication for public health strategies.2012-2022 年中国杭州地区流行的广泛耐药结核的流行率和流行模式:对公共卫生策略的启示。
BMC Public Health. 2024 Oct 17;24(1):2859. doi: 10.1186/s12889-024-20273-7.
2
Toward tuberculosis elimination by understanding epidemiologic characteristics and risk factors in Hainan Province, China.为实现海南省结核病消除目标,了解其流行病学特征和危险因素。
Infect Dis Poverty. 2024 Feb 27;13(1):20. doi: 10.1186/s40249-024-01188-2.
3
Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hainan, China: from 2014 to 2019.
中国海南地区耐药结核分枝杆菌的流行状况和分子特征:2014 年至 2019 年。
BMC Microbiol. 2021 Jun 19;21(1):185. doi: 10.1186/s12866-021-02246-7.
4
Prevalence of Multidrug-Resistant Tuberculosis in Dalian, China: A Retrospective Study.中国大连耐多药结核病的患病率:一项回顾性研究
Infect Drug Resist. 2021 Mar 16;14:1037-1047. doi: 10.2147/IDR.S294611. eCollection 2021.
5
Primary Drug-Resistance Pattern and Trend in Elderly Tuberculosis Patients in Shandong, China, from 2004 to 2019.2004年至2019年中国山东省老年结核病患者的原发性耐药模式及趋势
Infect Drug Resist. 2020 Nov 13;13:4133-4145. doi: 10.2147/IDR.S277203. eCollection 2020.
6
Survival Analysis of Risk Factors for Mortality in a Cohort of Patients with Tuberculosis.结核病患者队列中死亡率危险因素的生存分析。
Can Respir J. 2020 Sep 5;2020:1654653. doi: 10.1155/2020/1654653. eCollection 2020.
7
Treatment outcomes of multidrug-resistant tuberculosis in Hangzhou, China, 2011 to 2015.2011年至2015年中国杭州耐多药结核病的治疗结果
Medicine (Baltimore). 2020 Jul 24;99(30):e21296. doi: 10.1097/MD.0000000000021296.
8
Genetic diversity and drug susceptibility patterns of the complex in Yunnan, China.中国云南地区复合体的遗传多样性和药物敏感性模式。
Biosci Rep. 2019 May 31;39(5). doi: 10.1042/BSR20181746.
9
Is knowledge retained by healthcare providers after training? A pragmatic evaluation of drug-resistant tuberculosis management in China.培训后医疗保健提供者是否保留知识?中国耐多药结核病管理的实用性评估。
BMJ Open. 2019 Mar 23;9(3):e024196. doi: 10.1136/bmjopen-2018-024196.
10
Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China.中国贵州省某大型医院的耐药结核病耐药谱及趋势
Infect Drug Resist. 2019 Jan 10;12:211-219. doi: 10.2147/IDR.S188538. eCollection 2019.